Cargando…
Correlation Between Anosmia and Severity Along with Requirement of Tocilizumab in COVID-19 Patients
Anosmia with or without dysgeusia is frequently associated with Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) SARS-CoV-2 infection. SARS-CoV-2 virus affects the olfactory system and thus represents neurotropic and neuro-invasive nature of the virus. We found that tocilizumab’s role in...
Autores principales: | Silu, Manju, Mathur, Navneet Prasad, Kumari, Rekha, Chaudhary, Pallavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211308/ https://www.ncbi.nlm.nih.gov/pubmed/34178610 http://dx.doi.org/10.1007/s12070-021-02679-6 |
Ejemplares similares
-
Loosening of Teeth, an Unusual Presentation of Mucormycosis in COVID-19 Infected Patients
por: Mathur, Navneet Prasad, et al.
Publicado: (2023) -
Anosmia and dysgeusia as markers of severity and prognosis in COVID-19
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2023) -
The aftermath of COVID-19: between anosmia and ageusia()
por: Medina Gamero, Aldo, et al.
Publicado: (2022) -
Anosmia in COVID-19 patients
por: Hornuss, D., et al.
Publicado: (2020) -
Features of anosmia in COVID-19
por: Klopfenstein, T., et al.
Publicado: (2020)